Major system toxicities and side effects of anticonvulsants

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 14, 2001, Pages 16-21

  Swann, A C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; AZATHIOPRINE; CARBAMAZEPINE; CLONAZEPAM; DONNATAL; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MINOCYCLINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TERBINAFINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; COGNITIVE DEFECT; DRUG CONTRAINDICATION; DRUG HYPERSENSITIVITY; DRUG MILK LEVEL; DRUG SAFETY; HUMAN; HYPERANDROGENISM; LACTATION; LIVER TOXICITY; MANIC DEPRESSIVE PSYCHOSIS; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RASH; TERATOGENICITY;

ANTICONVULSANTS; BIPOLAR DISORDER; BREAST FEEDING; COGNITION DISORDERS; DRUG HYPERSENSITIVITY; ENDOCRINE SYSTEM DISEASES; EXANTHEMA; FEMALE; FETAL DISEASES; HUMANS; LIVER DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS; WEIGHT GAIN;

EID: 0034954068     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Cognitive effects of valproate
2. Tolerability of oral loading of divalproex sodium in the treatment of acute mania
3. Divalproex treatment of mania in elderly patients
4. Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series
5. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
6. Safety of topiramate: Adverse events and relationships to dosing
7. Phenytoin and carbamazepine: Differential effects on cognitive function
8. Sedative or antimanic effects of carbamazepine and treatment of behavioral dyscontrol
9. Motor activity in depressed patients treated with carbamazepine
10. Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy
11. Carbamazepine, hepatotoxicity, organic solvents, and paints
12. Suspected carbamazepine-induced hepatotoxicity
13. Acute hepatic failure in a child treated with lamotrigine
14. Potential hepatotoxicity of lamotrigine
15. Topiramate and fulminant liver failure
16. Severe hepatotoxicity during valproate therapy: An update and report of eight new fatalities
17. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: Review of valproate hepatotoxicity in adults
18. Drug-induced immunotoxicity
19. Bodyweight change as an adverse effect of drug treatment: Mechanisms and management
20. Weight gain associated with use of psychotropic medications
21. Weight gain in epileptic patients during treatment with valproic acid: A retrospective study
22. Changes in body weight with chronic, high-dose gabapentin therapy
23. Weight gain and gabapentin therapy
24. Metabolic changes during treatment with valproate in humans: Implication for untoward weight gain
25. Reduction in blood free carnitine levels in association with changes in sodium valproate (VPA) disposition in epileptic patients treated with VPA and other anti-epileptic drugs
26. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance
27. Carnitine deficiency in epilepsy: Risk factors and treatment
28. Heterozygotes for plasmalemmal carnitine transporter defect are at increased risk for valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts
29. Effect of long-term valproic acid administration on the efficiency of carnitine reabsorption in humans
30. Valproic acid overdose and L-carnitine therapy
31. Effect of L-carnitine supplementation on acute valproate intoxication
32. Carnitine for valproic acid-induced hyperammonemia
33. Obesity and endocrine disorders in women taking valproate for epilepsy
34. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy
35. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy
36. Medication status and polycystic ovary syndrome in women with bipolar disorder: A preliminary report
37. The effects of epilepsy and its treatment on sexual and reproductive function
38. Cutaneous reactions to anticonvulsant medications
39. Rash complicating carbamazepine treatment
40. Antiepileptic drug hypersensitivity syndrome
41. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study
42. Colitis may be part of the antiepileptic drug hypersensitivity syndrome
43. Severe multisystemic hypersensitivity reaction to carbamazepine including dyserythropoietic anemia
44. A review of carbamazepine's hematologic reactions and monitoring recommendations
45. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs
46. Pharmacokinetics during pregnancy: Evidence-based maternal dose formulation
47. Pattern of malformations in the children of women treated with carbamazepine during pregnancy
48. Congenital malformations due to antiepileptic drugs
49. Spina bifida in infants of women treated with carbamazepine during pregnancy
50. Antiepileptic drug regimens and major congenital abnormalities in the offspring
51. Prenatal exposure to anticonvulsant drugs and spatial ability in adulthood
52. Body dimensions of infants exposed to antiepileptic drugs in utero: Observations spanning 25 years
53. A clinical study of 57 children with fetal anticonvulsant syndromes
54. Psychiatric medication during pregnancy: Understanding and minimizing risks
55. Anticonvulsants and breast feeding: A critical review
56. Mood stabilizers during breastfeeding: A review
57. Serum valproate levels in 6 breastfeeding mother-infant pairs
58. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs
59. Sodium valproate, pregnancy, and infantile liver failure
60. Use of psychotropic medications in breast-feeding women: Acute and prophylactic treatment
61. Lamotrigine in pregnancy: Pharmacokinetics during delivery, in the neonate, and during lactation